Print Issue: February 01, 2012

Abatacept May Benefit Some Lupus Nephritis Patients

CHICAGO—Adding abatacept to mycophenolate mofetil (MMF) and steroids does not significantly improve the time to complete renal response in patients with lupus nephritis (LN), according to the findings of a 12-month study presented at the 2011 American College of Rheumatology annual meeting.

Next post in Expert Q&A